Dietger Niederwieser (D Niederwieser)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 37

Top Venues

Bone marrow transplantation

Annals of hematology

Leukemia

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Hartmut Döhner, Courtney D D DiNardo, Andrew H Wei, Bob Löwenberg, Frederick Appelbaum, Charles F Craddock, Hervé Dombret, Benjamin L Ebert, Pierre Fenaux, Lucy A Godley, Robert P Hasserjian, Richard A Larson, Ross L Levine, Yasushi Miyazaki, Dietger Niederwieser, Gert J Ossenkoppele, Christoph Röllig, Sierra Jorge, Eytan M Stein, Martin S Tallman, Hwei-Fang Tien, Jian-Xiang Wang, Agnieszka Świątek
Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations. Blood (2024)
Dietger Niederwieser, Thomas Lang, Rainer Krahl, Thomas Heinicke, Georg Maschmeyer, Haifa Kathrin Al-Ali, Sebastian Schwind, Madlen Jentzsch, Michael Cross, Christoph Kahl, Hans-Heinrich Wolf, Herbert Sayer, Antje Schulze, Peter Dreger, Ute Hegenbart, Alwin Krämer, Christian Junghanss, Lars-Olof Mügge, Detlev Hähling, Carsten Hirt, Christian Späth, Norma Peter, Bernhard Opitz, Axel Florschütz, Kolja Reifenrath, Niklas Zojer, Sebastian Scholl, Wolfram Pönisch, Simone Heyn, Vladan Vucinic, Andreas Hochhaus, Carlo Aul, Aristoteles Giagounidis, Leopold Balleisen, Bernd Oldenkott, Peter Staib, Michael Kiehl, Wolfgang Schütte, Ralph Naumann, Hartmut Eimermacher, Bernd Dörken, Cristina Sauerland, Eva Lengfelder, Wolfgang Hiddemann, Bernhard Wörmann, Carsten Müller-Tidow, Hubert Serve, Christoph Schliemann, Rüdiger Hehlmann, Wolfgang E Berdel, Markus Pfirrmann, Utz Krug, Verena S Hoffmann
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study. Annals of hematology 102 (3) (2023)
Dietger Niederwieser, Thomas Lang, Rainer Krahl, Thomas Heinicke, Georg Maschmeyer, Haifa Kathrin Al-Ali, Sebastian Schwind, Madlen Jentzsch, Michael Cross, Christoph Kahl, Hans-Heinrich Wolf, Herbert Sayer, Antje Schulze, Peter Dreger, Ute Hegenbart, Alwin Krämer, Christian Junghanss, Lars-Olof Mügge, Detlev Hähling, Carsten Hirt, Christian Späth, Norma Peter, Bernhard Opitz, Axel Florschütz, Kolja Reifenrath, Niklas Zojer, Sebastian Scholl, Wolfram Pönisch, Simone Heyn, Vladan Vucinic, Andreas Hochhaus, Carlo Aul, Aristoteles Giagounidis, Leopold Balleisen, Bernd Oldenkott, Peter Staib, Michael Kiehl, Wolfgang Schütte, Ralph Naumann, Hartmut Eimermacher, Bernd Dörken, Cristina Sauerland, Eva Lengfelder, Wolfgang Hiddemann, Bernhard Wörmann, Carsten Müller-Tidow, Hubert Serve, Christoph Schliemann, Rüdiger Hehlmann, Wolfgang E Berdel, Markus Pfirrmann, Utz Krug, Verena S Hoffmann
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study. Annals of hematology 102 (3) (2023)
Dietger Niederwieser, Thomas Lang, Rainer Krahl, Thomas Heinicke, Georg Maschmeyer, Haifa Kathrin Al-Ali, Sebastian Schwind, Madlen Jentzsch, Michael Cross, Christoph Kahl, Hans-Heinrich Wolf, Herbert Sayer, Antje Schulze, Peter Dreger, Ute Hegenbart, Alwin Krämer, Christian Junghanss, Lars-Olof Mügge, Detlev Hähling, Carsten Hirt, Christian Späth, Norma Peter, Bernhard Opitz, Axel Florschütz, Kolja Reifenrath, Niklas Zojer, Sebastian Scholl, Wolfram Pönisch, Simone Heyn, Vladan Vucinic, Andreas Hochhaus, Carlo Aul, Aristoteles Giagounidis, Leopold Balleisen, Bernd Oldenkott, Peter Staib, Michael Kiehl, Wolfgang Schütte, Ralph Naumann, Hartmut Eimermacher, Bernd Dörken, Cristina Sauerland, Eva Lengfelder, Wolfgang Hiddemann, Bernhard Wörmann, Carsten Müller-Tidow, Hubert Serve, Christoph Schliemann, Rüdiger Hehlmann, Wolfgang E Berdel, Markus Pfirrmann, Utz Krug, Verena S Hoffmann
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study. Annals of hematology (2023)
Dietger Niederwieser, Thomas Lang, Rainer Krahl, Thomas Heinicke, Georg Maschmeyer, Haifa Kathrin Al-Ali, Sebastian Schwind, Madlen Jentzsch, Michael Cross, Christoph Kahl, Hans-Heinrich Wolf, Herbert Sayer, Antje Schulze, Peter Dreger, Ute Hegenbart, Alwin Krämer, Christian Junghanss, Lars-Olof Mügge, Detlev Hähling, Carsten Hirt, Christian Späth, Norma Peter, Bernhard Opitz, Axel Florschütz, Kolja Reifenrath, Niklas Zojer, Sebastian Scholl, Wolfram Pönisch, Simone Heyn, Vladan Vucinic, Andreas Hochhaus, Carlo Aul, Aristoteles Giagounidis, Leopold Balleisen, Bernd Oldenkott, Peter Staib, Michael Kiehl, Wolfgang Schütte, Ralph Naumann, Hartmut Eimermacher, Bernd Dörken, Cristina Sauerland, Eva Lengfelder, Wolfgang Hiddemann, Bernhard Wörmann, Carsten Müller-Tidow, Hubert Serve, Christoph Schliemann, Rüdiger Hehlmann, Wolfgang E Berdel, Markus Pfirrmann, Utz Krug, Verena S Hoffmann
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study. Annals of hematology 102 (3) (2023)
Dietger Niederwieser, Thomas Lang, Rainer Krahl, Thomas Heinicke, Georg Maschmeyer, Haifa Kathrin Al-Ali, Sebastian Schwind, Madlen Jentzsch, Michael Cross, Christoph Kahl, Hans-Heinrich Wolf, Herbert Sayer, Antje Schulze, Peter Dreger, Ute Hegenbart, Alwin Krämer, Christian Junghanss, Lars-Olof Mügge, Detlev Hähling, Carsten Hirt, Christian Späth, Norma Peter, Bernhard Opitz, Axel Florschütz, Kolja Reifenrath, Niklas Zojer, Sebastian Scholl, Wolfram Pönisch, Simone Heyn, Vladan Vucinic, Andreas Hochhaus, Carlo Aul, Aristoteles Giagounidis, Leopold Balleisen, Bernd Oldenkott, Peter Staib, Michael Kiehl, Wolfgang Schütte, Ralph Naumann, Hartmut Eimermacher, Bernd Dörken, Cristina Sauerland, Eva Lengfelder, Wolfgang Hiddemann, Bernhard Wörmann, Carsten Müller-Tidow, Hubert Serve, Christoph Schliemann, Rüdiger Hehlmann, Wolfgang E Berdel, Markus Pfirrmann, Utz Krug, Verena S Hoffmann
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study. Annals of hematology 102 (3) (2023)
Dietger Niederwieser, Thomas Lang, Rainer Krahl, Thomas Heinicke, Georg Maschmeyer, Haifa Kathrin Al-Ali, Sebastian Schwind, Madlen Jentzsch, Michael Cross, Christoph Kahl, Hans-Heinrich Wolf, Herbert Sayer, Antje Schulze, Peter Dreger, Ute Hegenbart, Alwin Krämer, Christian Junghanss, Lars-Olof Mügge, Detlev Hähling, Carsten Hirt, Christian Späth, Norma Peter, Bernhard Opitz, Axel Florschütz, Kolja Reifenrath, Niklas Zojer, Sebastian Scholl, Wolfram Pönisch, Simone Heyn, Vladan Vucinic, Andreas Hochhaus, Carlo Aul, Aristoteles Giagounidis, Leopold Balleisen, Bernd Oldenkott, Peter Staib, Michael Kiehl, Wolfgang Schütte, Ralph Naumann, Hartmut Eimermacher, Bernd Dörken, Cristina Sauerland, Eva Lengfelder, Wolfgang Hiddemann, Bernhard Wörmann, Carsten Müller-Tidow, Hubert Serve, Christoph Schliemann, Rüdiger Hehlmann, Wolfgang E Berdel, Markus Pfirrmann, Utz Krug, Verena S Hoffmann
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study. Annals of hematology 102 (3) (2023)
Saskia Hell, Madlen Jentzsch, Georg-Nikolaus Franke, Nadja Jäkel, Susann Schulze, Jeanett Edelmann, Kolja Nenoff, Nora Grieb, Veljko Jeremic, Michael Cross, Sabine Leiblein, Enrica Bach, Wolfram Pönisch, Haifa Kathrin Al-Ali, Sebastian Schwind, Uwe Platzbecker, Thoralf Lange, Dietger Niederwieser, Vladan Vucinic
Prospective phase II study of preemptive chimerism-driven reduction of immunosuppression after non-myeloablative conditioning-Eudract #: 2007-002420-15. Bone marrow transplantation 57 (5) (2022)
Donata Backhaus, Dominic Brauer, Rosmarie Pointner, Lara Bischof, Vladan Vucinic, Georg-Nikolaus Franke, Dietger Niederwieser, Uwe Platzbecker, Madlen Jentzsch, Sebastian Schwind
A high hematopoietic cell transplantation comorbidity Index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older. Bone marrow transplantation (2022)
Cinthya Correa, Oscar Gonzalez-Ramella, Helen Baldomero, Ana Lisa Basquiera, Rosio Baena, Leonardo Arcuri, Bárbara Puga, Carmen Rosales, Marlene Chávez, Calixto Hernández, Bella Maldonado, Andrés Gómez-De León, Ninotchka Mendoza, Cristóbal Frutos, Lourdes Aranda, Lilián Díaz, Marcos Hernandez Jimenez, Adriana Seber, Amado J Karduss-Urueta, Gregorio Jaimovich, Juliana Martínez-Rolon, Carmem Maria Sales Bonfim, Hildegard T Greinix, Mickey B C Koh, Mahmoud Aljurf, Minako Iida, Wael Saber, Dietger Niederwieser, Yoshiko Atsuta, Sebastian Galeano, null null, null null
Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Bone marrow transplantation 57 (6) (2022)
Richard A Larson, Sumithra J Mandrekar, Lucas J Huebner, Ben L Sanford, Kristina Laumann, Susan Geyer, Clara D Bloomfield, Christian Thiede, Thomas W Prior, Konstanze Döhner, Guido Marcucci, Maria Teresa Teresa Voso, Rebecca B Klisovic, Ilene Galinsky, Andrew H Wei, Jorge Sierra, Miguel Angel Sanz, Joseph M Brandwein, Theo de Witte, Dietger Niederwieser, Frederick R Appelbaum, Bruno C Medeiros, Martin S Tallman, Jürgen Krauter, Richard F Schlenk, Arnold Ganser, Hubert Serve, Gerhard Ehninger, Sergio Amadori, Insa Gathmann, Hartmut Döhner, Richard M Stone
Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial. Leukemia 35 (9) (2021)
John O Mascarenhas, Rami S Komrokji, Francesca Palandri, Bruno Martino, Dietger Niederwieser, Andreas Reiter, Bart L Scott, Maria R Baer, Ronald Hoffman, Olatoyosi Odenike, Alessandro M Vannucchi, Jacqueline Bussolari, Eugene Zhu, Esther Rose, Laurie Sherman, Souria Dougherty, Libo Sun, Fei Huang, Ying Wan, Faye M Feller, Aleksandra Rizo, Jean-Jacques Kiladjian
Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (26) (2021)
Dietger Niederwieser
The Chinese HCT survey: a non-manipulated haploidentical transplantation procedure makes a novel contribution to data sharing within the regional and global transplant registries and to worldwide knowledge. Bone marrow transplantation 56 (6) (2021)
Guillermo Garcia Manero, Valeria Santini, Antonio Almeida, Uwe Platzbecker, Anna Jonasova, Lewis R Silverman, Jose Falantes, Gianluigi Reda, Francesco Buccisano, Pierre Fenaux, Rena Buckstein, Maria Diez Campelo, Stephen Larsen, David Valcarcel, Paresh Vyas, Valentina Giai, Esther Natalie Oliva, Jake Shortt, Dietger Niederwieser, Moshe Mittelman, Luana Fianchi, Ignazia La Torre, Jianhua Zhong, Eric Laille, Daniel Lopes de Menezes, Barry Skikne, C L Beach, Aristoteles Giagounidis
Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (13) (2021)
Marina Scheller, Anne Kathrin Ludwig, Stefanie Göllner, Christian Rohde, Stephen Krämer, Sina Stäble, Maike Janssen, James-Arne Müller, Lixiazi He, Nicole Bäumer, Christian Arnold, Joachim Gerß, Maximilian Schönung, Christian Thiede, Christian Niederwieser, Dietger Niederwieser, Hubert Serve, Wolfgang E Berdel, Ulrich Thiem, Inga Hemmerling, Florian Leuschner, Christoph Plass, Matthias Schlesner, Judith Barbara Zaugg, Michael D Milsom, Flavia Carla Meotti, Caroline Pabst, Daniel B Lipka, Carsten Muller-Tidow
Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response. Nature cancer 2 (5) (2021)
Frank G Rücker, Ling Du, Tamara J Luck, Axel Benner, Julia Krzykalla, Insa Gathmann, Maria Teresa Teresa Voso, Sergio Amadori, Thomas W Prior, Joseph M Brandwein, Frederick R Appelbaum, Bruno C Medeiros, Martin S Tallman, Lynn Savoie, Jorge Sierra, Celine Pallaud, Miguel Angel Sanz, Joop H Jansen, Dietger Niederwieser, Thomas Fischer, Gerhard Ehninger, Michael Heuser, Arnold Ganser, Lars Bullinger, Richard A Larson, Clara D Bloomfield, Richard M Stone, Hartmut Döhner, Christian Thiede, Konstanze Döhner
Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results. Leukemia (2021)
Madlen Jentzsch, Juliane Grimm, Marius Bill, Johannes Küpper, Donata Backhaus, Dominic Brauer, Julia Schulz, Georg-Nikolaus Franke, Vladan Vucinic, Dietger Niederwieser, Uwe Platzbecker, Sebastian Schwind
Measurable residual disease of canonical versus non-canonical DNMT3A, TET2, or ASXL1 mutations in AML at stem cell transplantation. Bone marrow transplantation 56 (10) (2021)
Thomas Heinicke, Rainer Krahl, Christoph Kahl, Michael Cross, Sebastian Scholl, Hans-Heinrich Wolf, Detlev Hähling, Ute Hegenbart, Norma Peter, Antje Schulze, Axel Florschütz, Volker Schmidt, Kolja Reifenrath, Niklas Zojer, Christian Junghanss, Herbert G Sayer, Georg Maschmeyer, Christian Späth, Andreas Hochhaus, Thomas Fischer, Haifa Kathrin Al-Ali, Dietger Niederwieser
Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials. Annals of hematology 100 (9) (2021)
Madlen Jentzsch, Juliane Grimm, Marius Bill, Dominic Brauer, Donata Backhaus, Julia Schulz, Karoline Goldmann, Dietger Niederwieser, Uwe Platzbecker, Sebastian Schwind
Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation. Blood cancer journal 11 (4) (2021)
Wolfgang Andreas Bethge, Matthias Eyrich, Stephan Mielke, Richard P Meisel, Dietger Niederwieser, Paul G Schlegel, Ansgar S Schulz, Johann Greil, Donald Bunjes, Arne Brecht, Jürgen H E Kuball, Michael Schumm, Vladan Vucinic, Markus Wiesneth, Halvard Bonig, Kasper Westinga, Stefanie Biedermann, Silke Holtkamp, Sandra Karitzky, Michaela Malchow, Christiane Siewert, Rupert Handgretinger, Peter Lang
Results of a multicenter phase I/II trial of TCRαβ and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients. Bone marrow transplantation 57 (3) (2021)
Dietger Niederwieser, Caroline Hamm, Patrick Cobb, Mindy Mo, Cecily Forsyth, Alessandra Tucci, Vladimir Hanes, Vincent Delwail, Roman Hajek, David Chien
Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product. Targeted oncology 15 (5) (2021)
J Loke, Myriam Labopin, Charles F Craddock, Dietger Niederwieser, J Cornelissen, B Afansayev, P Jindra, J Maertens, Didier Blaise, K Boriskina, M Gramatzki, A Ganser, B Savani, M Mohty, Arnon Nagler
Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT. Bone marrow transplantation 56 (3) (2020)
Thoralf Lange, Christian Niederwieser, Arthur Gil, Rainer Krahl, Ulrich von Grünhagen, Haifa Kathrin Al-Ali, Kathleen Jentsch-Ullrich, Claudia Spohn, Volker Lakner, Michael Assmann, Christian Junghanss, Michael Cross, Rüdiger Hehlmann, Michael Deininger, Markus Pfirrmann, Dietger Niederwieser
No advantage of Imatinib in combination with hydroxyurea over Imatinib monotherapy: a study of the East German Study Group (OSHO) and the German CML study group. Leukemia & lymphoma 61 (12) (2020)
Tapani Ruutu, Steffie van der Werf, Anja van Biezen, Janne T Backman, Christophe Peczynski, Nicolaus Kröger, Mohamad Mohty, Arnon Nagler, Silvia Montoto, Claudia Langebrake, Dietger Niederwieser, Zinaida Peric, Christian Koenecke, Rafael F Duarte, Grzegorz Władysław Basak
Use of busulfan in conditioning for allogeneic hematopoietic stem cell transplantation in adults: a survey by the Transplant Complications Working Party of the EBMT. Bone marrow transplantation 54 (12) (2019)
Ibrahim N Muhsen, Shahrukh K Hashmi, Dietger Niederwieser, Nicolaus Kroeger, Samir Agrawal, Marcelo C Pasquini, Yoshiko Atsuta, Karen K Ballen, Adriana Seber, Wael Saber, Mohamed A Kharfan-Dabaja, Walid Rasheed, Shinichiro Okamoto, Nandita Khera, William A Wood, Mickey B C Koh, Hildegard Greinix, Yoshihisa Kodera, Jeffrey Szer, Mary M Horowitz, Daniel Weisdorf, Mahmoud Aljurf
Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries. Bone marrow transplantation 55 (4) (2019)
Thomas Karlas, Tina Weiße, David Petroff, Sebastian Beer, Christine Döhring, Franziska Gnatzy, Dietger Niederwieser, Gerhard Behre, Joachim Mössner, Janett Fischer, Michael Tröltzsch, Johannes Wiegand, Volker Keim, Georg-Nikolaus Franke
Predicting hepatic complications of allogeneic hematopoietic stem cell transplantation using liver stiffness measurement. Bone marrow transplantation 54 (11) (2019)
Mazyar Shadman, David G Maloney, Barry Storer, Brenda M Sandmaier, Thomas R Chauncey, Niels Smedegaard Andersen, Dietger Niederwieser, Judith A Shizuru, Benedetto Bruno, Michael A Pulsipher, Richard T Maziarz, Edward D Agura, Parameswaran Hari, Amelia A Langston, Michael B Maris, Peter A McSweeney, Rainer Storb, Mohamed Lotfy Sorror
Rituximab-based allogeneic transplant for chronic lymphocytic leukemia with comparison to historical experience. Bone marrow transplantation 55 (1) (2019)
Thomas Heinicke, Myriam Labopin, Emmanuelle Polge, Dietger Niederwieser, Uwe Platzbecker, Henrik Sengelov, Goda Choi, Jan Cornelissen, Didier Blaise, Jürgen Kuball, Gwendolyn van Gorkom, Nicolaas Schaap, Victoria Potter, Franciane Paul, Bipin N Savani, Arnon Nagler, Mohamad Mohty
Fludarabine/busulfan versus fludarabine/total-body-irradiation (2 Gy) as conditioning prior to allogeneic stem cell transplantation in patients (≥60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMT. Bone marrow transplantation 55 (4) (2019)
Mahmoud Aljurf, Daniel Weisdorf, Feras Alfraih, Jeffrey Szer, Carlheinz Müller, Dennis Confer, Shahrukh Hashmi, Nicolaus Kröger, Bronwen E Shaw, Hildegard Greinix, Mohamed A Kharfan-Dabaja, Lydia Foeken, Adriana Seber, Syed Ahmed, Areej El-Jawahri, Moheeb Al-Awwami, Yoshiko Atsuta, Marcelo Pasquini, Amr Hanbali, Hazzaa Alzahrani, Shinichiro Okamoto, Eliane Gluckman, Mohamad Mohty, Yoshihisa Kodera, Mary Horowitz, Dietger Niederwieser, Riad El Fakih
"Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries". Bone marrow transplantation 54 (8) (2019)
Hanneke C Kluin-Nelemans, Andreas Reiter, Anja Illerhaus, Bjorn van Anrooij, Karin Hartmann, Lambertus F R Span, Aleksandra Gorska, Marek Niedoszytko, Magdalena Lange, Luigi Scaffidi, Roberta Zanotti, Patrizia Bonadonna, Cecelia Perkins, Chiara Elena, Luca Malcovati, Khalid Shoumariyeh, Nikolas von Bubnoff, Roberta Parente, Massimo Triggiani, Juliana Schwaab, Mohamad Jawhar, Francesca Caroppo, Anna Belloni Fortina, Knut Brockow, Alexander Zink, David Fuchs, Alex Kilbertus, Akif Selim Yavuz, Michael Doubek, Mattias Mattsson, Hans Hagglund, Jens Panse, Vito Sabato, Elisabeth Aberer, Dietger Niederwieser, Christine Breynaert, Judit Várkonyi, Vanessa Kennedy, Olivier Lortholary, Thilo Jakob, Olivier Hermine, Julien Rossignol, Michel Arock, Jason Gotlib, Peter Valent, Wolfgang R Sperr
Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry. Leukemia 34 (4) (2019)
Juliane Grimm, Marius Bill, Madlen Jentzsch, Stefanie Beinicke, Janine Häntschel, Karoline Goldmann, Julia Schulz, Michael Cross, Georg-Nikolaus Franke, Gerhard Behre, Vladan Vucinic, Wolfram Pönisch, Thoralf Lange, Dietger Niederwieser, Sebastian Schwind
Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation. Bone marrow transplantation 54 (8) (2018)
Johannes Schetelig, Liesbeth C de Wreede, Michel van Gelder, Linda Koster, Jürgen Finke, Dietger Niederwieser, Dietrich Beelen, G J Mufti, Uwe Platzbecker, Arnold Ganser, Silke Heidenreich, Johan Maertens, Gerard Socié, Arne Brecht, Matthias Stelljes, Guido Kobbe, Liisa Volin, Arnon Nagler, Antonin Vitek, Thomas Luft, Per Ljungman, Ibrahim Yakoub-Agha, Marie Robin, Nicolaus Kröger
Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia. Leukemia 33 (3) (2018)
Kazimierz Halaburda, Myriam Labopin, Mohamed Houhou, Dietger Niederwieser, Jürgen Finke, Liisa Volin, Johan Maertens, Jan J Cornelissen, Noel Milpied, Gernot Stuhler, Nicolaus Kröger, Jordi Esteve, Mohamad Mohty, Arnon Nagler
AlloHSCT for inv(3)(q21;q26)/t(3;3)(q21;q26) AML: a report from the acute leukemia working party of the European society for blood and marrow transplantation. Bone marrow transplantation 53 (6) (2018)
Tatjana Bilich, Annika Nelde, Leon Bichmann, Malte Roerden, Helmut R Salih, Daniel J Kowalewski, Heiko Schuster, Chih-Chiang Tsou, Ana Marcu, Marian Christoph Neidert, Maren Lübke, Jonas Rieth, Mirle Schemionek-Reinders, Tim Henrik Brümmendorf, Vladan Vucinic, Dietger Niederwieser, Jens Bauer, Melanie Märklin, Janet K Peper, Reinhild Klein, Oliver Kohlbacher, Lothar Kanz, Hans-Georg Rammensee, Stefan Stevanović, Juliane Sarah Walz
The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy. Blood 133 (6) (2018)
Peter Dreger, Mauricette Michallet, Paul Bosman, Sascha Dietrich, Mohamad Sobh, Ariane Boumendil, Arnon Nagler, Christof Scheid, Jan Cornelissen, Dietger Niederwieser, Lutz Müller, Elizabeth Vandenberghe, Ilaria Scortechini, Hélène M Schoemans, Niels S Andersen, Jürgen Finke, Domenico Russo, Qamar-Un-Nisa Chaudhry, Jakob Passweg, Michel van Gelder, Nadira Durakovic, Helene Labussiere-Wallet, Tobias Berg, Gerald Wulf, Wolfgang Bethge, Donald Bunjes, Stefan Stilgenbauer, Maria Elisa Canepari, Michel Schaap, Christopher P Fox, Nicolaus Kröger, Silvia Montoto, Johannes Schetelig
Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties. Bone marrow transplantation 54 (1) (2018)
Helen Baldomero, Mahmoud Aljurf, Syed Z A Zaidi, Shahrukh K Hashmi, Ardeshir Ghavamzadeh, Alaa Elhaddad, Rose-Marie Hamladji, Parvez Ahmed, Lamia Torjemane, Miguel Abboud, Abdelghani Tbakhi, Murtadha Al Khabori, Asma El Quessar, Nosa Bazuaye, Mohamed Amine Bekadja, Salman Adil, Omar Fahmy, Mani Ramzi, Ahmed Ibrahim, Amal Alseraihy, Nour Ben Abdejalil, Mahmoud Sarhan, Mohammed Al Huneini, Lahoucine Mahmal, Hassan ElSolh, Fazal Hussain, Amr Nassar, Hani Al-Hashmi, Amir Ali Hamidieh, Marcelo Pasquini, Yoshihisa Kodera, Nicolaus Kröger, Mohamed Mohty, Gregorio Jaimovich, Juliana Martinez Rolon, Kristjan Paulson, Hildegard Greinix, Daniel Weisdorf, Mary Horowitz, José Nunez, Alois Gratwohl, Jacob Passweg, Mickey Koh, Jeffrey Szer, Dietger Niederwieser, Nicolas Novitzky, null null
Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends. Bone marrow transplantation 54 (3) (2018)
Ivan Sergeevich Moiseev, Tatyana Tsvetkova, Mahmoud Aljurf, Randa M Alnounou, Janet Bogardt, Yves Chalandon, Mikhail Yu Drokov, Valentina Dvirnyk, Maura Faraci, Lone Smidstrup Friis, Fabio Giglio, Hildegard T Greinix, Brian Thomas Kornblit, Christiane Koelper, Christian Koenecke, Krzysztof Lewandowski, Dietger Niederwieser, Jakob R Passweg, Christophe Peczynski, Olaf Penack, Zinaida Peric, Agnieszka Piekarska, Paola Erminia Ronchi, Alicia Rovo, Piotr Rzepecki, Francesca Scuderi, Daniel Sigrist, Sanna M Siitonen, Friedrich Stoelzel, Kazimierz Sulek, Dimitrios A Tsakiris, Urszula Wilkowojska, Rafael F Duarte, Tapani Ruutu, Grzegorz Władysław Basak
Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT. Bone marrow transplantation 54 (7) (2018)

Dietger Niederwieser.css-eqlu8i{font-size:small;padding-left:4px;} (D Niederwieser)

Publication Activity (10 Years)

Top Topics

Top Venues

Dietger Niederwieser (D Niederwieser)